share_log

Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Market Cap Increased by CN¥634m, Insiders Receive a 46% Cut

Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Market Cap Increased by CN¥634m, Insiders Receive a 46% Cut

深圳利福電子科技有限公司's (SHSE: 688389) 市值增加了6.34億元人民幣,內部人士獲得 46% 的下調
Simply Wall St ·  04/25 21:39

Key Insights

關鍵見解

  • Insiders appear to have a vested interest in Shenzhen Lifotronic Technology's growth, as seen by their sizeable ownership
  • 53% of the business is held by the top 6 shareholders
  • 23% of Shenzhen Lifotronic Technology is held by Institutions
  • 業內人士似乎對深圳利福強科技的增長有既得利益,從他們龐大的所有權可以看出
  • 53% 的業務由前6名股東持有
  • 深圳利福電子科技23%的股份由機構持有

To get a sense of who is truly in control of Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 46% to be precise, is individual insiders. Put another way, the group faces the maximum upside potential (or downside risk).

要了解誰真正控制了深圳利福電子科技有限公司(SHSE: 688389),了解業務的所有權結構非常重要。持有公司股份最多的集團是個人內部人士,準確地說約爲46%。換句話說,該集團面臨最大的上行潛力(或下行風險)。

As a result, insiders were the biggest beneficiaries of last week's 8.5% gain.

因此,內部人士是上週8.5%漲幅的最大受益者。

Let's delve deeper into each type of owner of Shenzhen Lifotronic Technology, beginning with the chart below.

讓我們從下圖開始,深入研究深圳Lifotronic Technology的每種類型的所有者。

ownership-breakdown
SHSE:688389 Ownership Breakdown April 26th 2024
SHSE: 688389 所有權明細 2024 年 4 月 26 日

What Does The Institutional Ownership Tell Us About Shenzhen Lifotronic Technology?

關於深圳利福強科技,機構所有權告訴我們什麼?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

機構在向自己的投資者報告時通常會根據基準來衡量自己,因此,一旦股票被納入主要指數,他們通常會對股票更加熱情。我們預計大多數公司都會有一些機構在冊,尤其是在它們正在成長的情況下。

Shenzhen Lifotronic Technology already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shenzhen Lifotronic Technology, (below). Of course, keep in mind that there are other factors to consider, too.

深圳利福強科技已經在股份登記處設立了機構。事實上,他們擁有該公司可觀的股份。這可能表明該公司在投資界具有一定程度的信譽。但是,最好謹慎行事,不要依賴機構投資者所謂的驗證。他們也是,有時候會弄錯。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得查看深圳立豐科技過去的盈利軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
SHSE:688389 Earnings and Revenue Growth April 26th 2024
SHSE: 688389 收益和收入增長 2024 年 4 月 26 日

Shenzhen Lifotronic Technology is not owned by hedge funds. Xiancheng Liu is currently the largest shareholder, with 29% of shares outstanding. Shenzhen Hanyu Biotechnology Partnership Enterprise (Limited Partnership) is the second largest shareholder owning 5.0% of common stock, and Ming Long Hu holds about 4.9% of the company stock. Ming Long Hu, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors.

深圳利福強科技不歸對沖基金所有。劉先成目前是最大股東,已發行股份的29%。深圳漢宇生物科技合夥企業(有限合夥)是第二大股東,擁有5.0%的普通股,胡明龍持有公司約4.9%的股份。第三大股東胡明龍也恰好擁有董事會成員的頭銜。

On further inspection, we found that more than half the company's shares are owned by the top 6 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.

經過進一步檢查,我們發現公司一半以上的股份由前六名股東持有,這表明較大股東的利益在一定程度上被較小的股東所平衡。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

雖然研究公司的機構所有權可以爲您的研究增加價值,但研究分析師的建議以更深入地了解股票的預期表現也是一種好做法。有相當數量的分析師在報道該股,因此了解他們對未來的總體看法可能很有用。

Insider Ownership Of Shenzhen Lifotronic Technology

深圳利福電子科技的內部所有權

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

儘管內部人士的確切定義可能是主觀的,但幾乎每個人都認爲董事會成員是內部人士。公司管理層經營業務,但首席執行官將對董事會負責,即使他或她是董事會成員。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部所有權是一件好事。但是,在某些情況下,這使其他股東更難追究董事會對決策的責任。

Our information suggests that insiders maintain a significant holding in Shenzhen Lifotronic Technology Co., Ltd.. It is very interesting to see that insiders have a meaningful CN¥3.7b stake in this CN¥8.1b business. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

我們的信息表明,內部人士持有深圳Lifotronic科技有限公司的大量股份。有趣的是,內部人士在這項81億元的業務中擁有37億元人民幣的大量股份。很高興看到這樣的投資水平。你可以在這裏查看這些內部人士最近是否在買入。

General Public Ownership

一般公有制

The general public-- including retail investors -- own 20% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

包括散戶投資者在內的公衆擁有該公司20%的股份,因此不容忽視。儘管這種所有權規模可能不足以影響對他們有利的政策決定,但它們仍然可以對公司政策產生集體影響。

Private Company Ownership

私人公司所有權

Our data indicates that Private Companies hold 9.3%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我們的數據顯示,私營公司持有公司9.3%的股份。僅憑這一事實很難得出任何結論,因此值得研究誰擁有這些私營公司。有時,內部人士或其他關聯方通過一家獨立的私人公司對上市公司的股份擁有權益。

Next Steps:

後續步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 1 warning sign for Shenzhen Lifotronic Technology you should be aware of.

我覺得看看究竟誰擁有一家公司非常有趣。但是,要真正獲得見解,我們還需要考慮其他信息。一個很好的例子:我們發現了你應該注意的深圳利福電子科技的1個警告信號。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一樣,你可能需要考慮這家公司是會成長還是會萎縮。幸運的是,您可以查看這份免費報告,其中顯示了分析師對其未來的預測。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論